Related Experiment Video

Updated: Sep 14, 2025

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.0K

Exploring Potential Therapeutic Applications of Tazarotene: Gene Regulation Mechanisms and Effects on Melanoma Cell

Chun-Hua Wang1,2, Lu-Kai Wang3, Fu-Ming Tsai4

  • 1Department of Dermatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.

Current Issues in Molecular Biology
|July 23, 2025
PubMed

Insights

Tazarotene, a retinoid derivative, shows promise for treating melanoma in situ by regulating genes involved in cell growth and immune response. This review explores its antitumor mechanisms and potential as a topical therapy.

Area of Science:

  • Dermatology
  • Oncology
  • Molecular Biology

Background:

  • Tazarotene is a retinoid derivative used for psoriasis and acne.
  • Emerging research highlights its potential in treating melanoma in situ.
  • Retinoids play a role in regulating cell processes relevant to cancer development.

Purpose of the Study:

  • To review the current use of retinoid derivatives, specifically tazarotene, in melanoma treatment.
  • To explore the molecular mechanisms of tazarotene's action in melanoma.
  • To assess tazarotene's potential clinical applications and challenges in melanoma therapy.

Main Methods:

  • Review of current literature on tazarotene and melanoma.
  • Analysis of molecular mechanisms involving retinoic acid receptors (RAR-β, RAR-γ) and target genes (TIG1, TIG2, TIG3).
  • Evaluation of tazarotene's role in gene regulation, cell proliferation, invasiveness, and immune response in the tumor microenvironment.

Main Results:

  • Tazarotene selectively activates RAR-β and RAR-γ, influencing genes critical for melanoma cell regulation.
  • Tazarotene demonstrates potential in suppressing melanoma growth via gene expression modulation.
  • Its impact on the tumor microenvironment and immune responses is under investigation.

Conclusions:

  • Tazarotene's mechanism involves regulating key genes (TIG1-3) through RAR activation.
  • It shows promise for melanoma in situ treatment, with potential roles in modulating immune responses.
  • Further research is needed to establish its clinical efficacy and optimize topical application strategies.
Keywords:
melanomaretinoic acidretinoic acid receptorsretinoid X receptorstazarotenetazarotene-induced gene

More Related Videos

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.6K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K